Chief Medical Officer Summit 360º Agenda 2026 Page 2

Anna Frostegård, MD, PhD, Co-Founder, Chief Scientific & Medical Officer, Annexin Pharmaceuticals

Jeff Humphrey, MD, CMO, Myris Therapeutics

Showing Events in 1 Track from 08:30am to 09:00am

R&D Leadership Keynote

8:30AM - 9:00AM

CMO Leadership Keynote

Daniel Quirk, MD, MPH, MBA, CMO & Head of Medical Affairs, Biogen

Showing Events in 1 Track from 09:00am to 09:30am

Keynote and Fireside Discussion

9:00AM - 9:30AM

Biotech Investment Banking Keynote and Fireside Discussion with HC Wainwright's Vice Chairman, Head of M&A and Strategic Advisory Services

Michael Meyers, Vice Chairman, Head of M&A and Strategic Advisory Services, HC Wainwright & Co.

Showing Events in 1 Track from 09:30am to 10:35am

Morning Break & Networking

9:30AM - 10:35AM

Morning Break & Networking

Showing Events in 1 Track from 10:35am to 12:35pm

Morning General Session Continued

10:35AM - 11:05AM

What Investors are Looking For in 2026

Jakob Dupont, MD, Executive Partner, Sofinnova Investments, Inc.

11:05AM - 11:20AM

Reserved Session

11:20AM - 11:50AM

What Pharma S&E/BD are Looking for in 2026

Moderator:

Harold Bernstein, MD, PhD, President, R&D and CMO, Maze Therapeutics

Panelists:

Jeremy Sokolove, MD, CMO, Vor Bio

Sarah Tao, PhD, Head of Search and Evaluation, Technology Platforms, Sanofi

11:50AM - 12:05PM

How CMOs Can Lead Cross-Functional Teams Without a Full Clinical Department

Samer Kaba, MD, Chief Medical Officer, Harbor Clinical

12:05PM - 12:35PM

Strategies to Accelerate Time to Inflection Point

Moderator:

Mohammed Asmal, MD, PhD, CMO, Prime Medicine

Panelists:

Aiden Flynn, PhD, Senior Vice President, Strategic Statistical Consulting, MMS

Richard Graham, PhD, Co-Founder and Chairman of the Board, TruTechnologies

Jason Sager, MD, CMO, Accent Therapeutics, Inc.

Abi Vainstein-Haras, MD, CMO, Sapience Therapeutics

Showing Events in 1 Track from 12:35pm to 01:35pm

Lunch

12:35PM - 1:35PM

Lunch

Showing 3 of 5 Tracks

from 01:35pm to 02:20pm

Wearables and Digital Biomarkers

Wearables and Digital Biomarkers

Irina Antonijevic, MD, PhD, CMO, Trace Neuroscience

Surrogate Endpoints and Biomarkers

Surrogate Endpoints and Biomarkers

Aaron Koenig, MD, CMO, Syndeio Biosciences

RWD/RWE and External Controls

RWD/RWE and External Controls

EHR2EDC

EHR2EDC

Optimizing Clinical Enrollment

Optimizing Clinical Enrollment

Showing 3 of 6 Tracks

from 02:20pm to 03:15pm

What to Look for Before Accepting the CMO Role

What to Look for Before Accepting the CMO Role

Carey Hwang, MD, PhD, CMO, IntegerBio

Thinking Strategically about your CMO Career

Thinking Strategically about your CMO Career

Arvin Yang, MD, PhD, CMO, Pheon Therapeutics

Getting a Seat on the Board

Getting a Seat on the Board

What a CMO Needs to Know About Becoming a CEO

What a CMO Needs to Know About Becoming a CEO

How to Think About a Fractional and Consulting CMO Roles

How to Think About a Fractional and Consulting CMO Roles

Andrew K Joe, MD, CMO Consultant, Pyxis Oncology

James Wooldridge, MD, CMO, Immunitas Therapeutics

Private and Public CMOs

Naiyer Rizvi, MD, CMO, Synthekine

Private and Public CMOs

Showing 3 of 6 Tracks

from 03:15pm to 04:00pm

Cell & Gene Therapy

Oncology

Patrick Zweidler-McKay, MD, PhD, Fractional CMO, Sidewinder Therapeutics, Neok Bio

CNS

CNS

Kemi Olugemo, MD, FAAN, President, Clinical Development Consulting, LLC

Rare Disease

Rare Disease

John Goldberg, MD, CMO, Rafael Holdings

Inflammation & Immunology

Inflammation & Immunology

Jennifer Low, MD, PhD, CEO, Wield Therapeutics

Cardiovascular/Metabolic

Cardiovascular/Metabolic